GENOME ANNOUNCEMENT
===================

The emergence of multidrug-resistant (MDR) strains for tuberculosis (TB) is resulting in one of the major worldwide public health problems. In 2012, the incidence rate for TB in Peru was 95 cases/100,000 population, of which 3.9% were new cases of MDR-TB ([@B1]), and from these MDR-TB cases, 79% were from Lima ([@B2]). Currently, there is no genomic information on an MDR strain from Peru. Thus, obtaining this information is a key step in understanding the biology of the pathogen and improving treatment for TB ([@B3]). Here, we report genomic features of a multidrug-resistant strain of *Mycobacterium tuberculosis*, INS-MDR, from a patient with active TB from Peru.

The establishment of this strain's lineage was based on 24 mycobacterial interspersed repetitive unit-variable number of tandem repeat (MIRU-VNTR) loci ([@B4]) and on single-nucleotide polymorphisms (SNPs) based on phylogeny ([@B5]). The genome sequencing of INS-MDR was performed using an Illumina HiSeq 2000 sequencer with coverage of 1,331×. Resulting paired-end reads were assembled with BWA v 0.5.9-r16 ([@B6]), using the H37Rv genome (NC000962.3) as a reference. The genomic sequence was annotated with the RAST server ([@B7]), Prokaryotic Genome Annotation Pipeline (PGAAP), and Clusters of Orthologous Groups (COG) ([@B8]) databases. A comparative analysis was carried out between INS-MDR and KZN 1435, an MDR strain from South Africa ([@B9]), using SNPsFinder ([@B10]) to identify the differences in intergenic coding regions and gene ontology classifications (COG).

It has been determined that INS-MDR belongs to the LAM lineage. We obtained 58,157,302 paired-end reads that, after the assembly, resulted in 22 contigs comprising about 99.98% compared to the H37Rv genome. INS-MDR is 4,383,671 bp long, with an average GC content of 65.6%.

A total of 805 polymorphisms with respect to H37Rv were observed, with 703 of these located in the coding regions that were classified in COG categories as follows: secondary metabolite biosynthesis, transport, and catabolism (*n* = 38); lipid transport and metabolism (*n* = 41); replication, recombination, and repair (*n* = 32); energy production and conversion (*n* = 35); amino acid transport and metabolism (*n* = 30); carbohydrate transport and metabolism (*n* = 27); cell motility (*n* = 21); cell wall/membrane/envelope biogenesis (M) (*n* = 23); coenzyme transport and metabolism (*n* = 22); signal transduction mechanisms (*n* = 22); inorganic ion transport and metabolism (*n* = 22); transcription (*n* = 20); translation, ribosomal structure, and biogenesis (*n* = 16); posttranslational modification and protein turnover (*n* = 13); nucleotide transport and metabolism (*n* = 11); defense mechanisms (*n* = 5); cell cycle control, cell division, and chromosome partitioning (*n* = 9); and RNA processing and modification (*n* = 2).

We identified a mutation on the *rpoB* gene (D516V) related to resistance to rifampin ([@B11]), mutations on the *katG* (S315T) and *kasA* genes (G269S) related to resistance to isoniazid ([@B12], [@B13]), and a mutation on the *pncA* gene (Q10R) related to pyrazinamide resistance ([@B14]). Also, we found mutations on the *gyrA* gene (E21Q, S95T, G247S, G668D) and a mutation on the *embB* gene (Y319S) that do not confer resistance ([@B15][@B16][@B17]).

Comparison of the KZN 1435 and INS-MDR strains demonstrated that, despite the differences in geographic origin and the high incidence of TB in South Africa ([@B1]), the strains have similar proportions of SNPs, showing high degrees of conservation of genome structure. These results suggest that the outbreak of drug-resistant tuberculosis in Lima may be a clonal expansion of the same strain; however, more genomic information is required.
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--------------------------------------

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession number [JAQI00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=JAQI00000000). The version described in this paper is version JAQI01000000.
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